The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

LETTER TO THE EDITOR

Indexed patent ductus arteriosus size as the prime predictor of post device closure left ventricular dysfunction: does it have any competitors?

EuroIntervention 2019;14:e. DOI: 10.4244/EIJ-D-18-00542L

Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India


In their study, Kiran et al propose the indexed patent ductus arteriosus (PDA) size at the pulmonary artery end as a simple predictor of post-procedural left ventricular (LV) dysfunction in those with baseline normal LV function1. Whilst we agree with the authors’ observation that the size of the PDA is an important prognostic marker, it is not uncommon to find a PDA where the diameter at the pulmonary artery end is not the minimum diameter. In such cases, the minimum PDA diameter indexed to body surface area may be an appropriate measure. Although this is by far the largest ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Reply to the letter to the editor by Garg “Indexed patent ductus arteriosus size as the prime predictor of post device closure left ventricular dysfunction: does it have any competitors?”